中超控股(002471.SZ):決定設立醫美投資決策諮詢委員會
格隆汇6月15日丨中超控股(002471.SZ)公布,公司于2021年6月15日召开第五届董事会第十次会议,审议通过《关于设立医美投资决策咨询委员会的议案》。
公司于2021年6月1日召开第五届董事会第八次会议审议通过《关于参与设立医疗健康产业基金的议案》,于2021年6月15日召开第五届董事会第十次会议审议通过《关于投资设立江苏中超医美健康投资管理有限公司的议案》,考虑到公司拟投资的医疗健康产业与公司现有电线电缆产业的差异性,为了降低公司跨行业投资的风险,提高投资回报,公司董事会决定设立医美投资决策咨询委员会,聘请具有医疗健康行业等管理经验的专业人员为公司把控风险,整合和发挥各方优势和资源,推进公司医疗健康板块运作,培育公司新的利润增长点。
根据《公司章程》有关规定,医疗健康产业相关议案需报公司相应决策机构审议或批准,审议决策前由此委员会提供建议和意见。
医美投资决策咨询委员会成员如下:主任:杨飞;首席顾问:王磊;副主任:陈洪兵、丁香;其他成员:曾令寰、杨毅、徐林虎、姚兴江、吴燕、潘志娟、李川冰。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.